PA(14:0/20:4(5Z,8Z,11Z,14Z)) (BioCAD00000109008)

{$topic}

Metabolite Card

Formula: C37H65O8P (668.4417)
SMILES: [H][C@@](COC(=O)CCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC

Synonyms [en]

PA(14:0/20:4(5Z,8Z,11Z,14Z)); 1-tetradecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycero-3-phosphate; PA(34:4) ; Phosphatidate(14:0/20:4n6) ; Phosphatidic acid(14:0/20:4) ; PA(14:0/20:4n6)

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

PA(14:0/20:4(5Z,8Z,11Z,14Z)). 数据之源，洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000109008). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

PA(14:0/20:4(5Z,8Z,11Z,14Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(14:0/20:4(5Z,8Z,11Z,14Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of arachidonic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

Entity Information

DBLinks

Other DBLinks
  • PubChem: 52929514
  • HMDB: HMDB0114785
  • LipidMaps: LMGP10010925
  • Metlin: METLIN_82091

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0073009 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z))
PathBank:SMP0073013 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z))
PathBank:SMP0073017 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0083349 Cardiolipin Biosynthesis CL(14:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0088274 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0088278 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0088282 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/24:0)
PathBank:SMP0016655 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/16:0)
PathBank:SMP0016659 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/24:0)
PathBank:SMP0016663 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z))
PathBank:SMP0016667 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/24:1(15Z))
PathBank:SMP0016671 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
PathBank:SMP0016675 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z))
PathBank:SMP0016679 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0095796 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:0)
PathBank:SMP0096960 Cardiolipin Biosynthesis CL(14:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:0)
PathBank:SMP0096964 Cardiolipin Biosynthesis CL(14:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z))
PathBank:SMP0064260 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z))
PathBank:SMP0064264 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z))
PathBank:SMP0064268 De Novo Triacylglycerol Biosynthesis TG(14:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
View All Pathways